 | • レポートコード：D0GIR-01434 • 出版社/出版日：GlobalInfoResearch / 2020年9月23日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、108ページ • 納品方法：Eメール • 産業分類：医療、製薬、バイオ |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、インフルエンザ予防接種の世界市場を広く調査・分析し、今後の市場展望をまとめております。インフルエンザ予防接種の種類別市場規模（卵ベース、細胞培養、組み換え）、用途別市場規模（病院、研究機関）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェアなどの情報を掲載しています。 ・市場概要 ・企業情報（販売量、市場シェア、製品概要、SWOT分析）：Abbott (U.S.)、Mitsubishi Tanabe Pharma Corporation (Asia Pacific)、Novartis AG (Europe)、AstraZeneca (Europe)、Hualan Biological Engineering Inc (Asia Pacific)、BioCryst Pharmaceuticals, Inc. (U.S.)、Sanofi (Europe)、GlaxoSmithKline plc. (Europe)、DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)、F. Hoffmann-La Roche Ltd (Europe) ・地域別グローバル市場分析 2015年-2020年 ・インフルエンザ予防接種の北米市場（アメリカ、カナダ、メキシコ） ・インフルエンザ予防接種のヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・インフルエンザ予防接種のアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・インフルエンザ予防接種の南米市場（ブラジル、アルゼンチン） ・インフルエンザ予防接種の中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：卵ベース、細胞培養、組み換え ・用途別分析：病院、研究機関 ・地域別市場規模予測 2021年-2025年 ・調査の結果・結論 |
Market Overview
The global Influenza Vaccination market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of 4.6% in the forecast period of 2020 to 2025 and will expected to reach USD 4308.7 million by 2025, from USD 3603 million in 2019.
The Influenza Vaccination market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Influenza Vaccination market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Influenza Vaccination market has been segmented into:
Egg Based
Cell Culture
Recombinant
By Application, Influenza Vaccination has been segmented into:
Hospitals
Research Organizations
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Influenza Vaccination market presented in the report. This section sheds light on the sales growth of different regional and country-level Influenza Vaccination markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Influenza Vaccination market.
The report offers in-depth assessment of the growth and other aspects of the Influenza Vaccination market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia and Australia)
South America (Brazil, Argentina, Colombia)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Competitive Landscape and Influenza Vaccination Market Share Analysis
Influenza Vaccination competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Influenza Vaccination sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Influenza Vaccination sales, revenue and market share for each player covered in this report.
The major players covered in Influenza Vaccination are:
Abbott (U.S.)
Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
Novartis AG (Europe)
AstraZeneca (Europe)
Hualan Biological Engineering Inc (Asia Pacific)
BioCryst Pharmaceuticals, Inc. (U.S.)
Sanofi (Europe)
GlaxoSmithKline plc. (Europe)
DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
F. Hoffmann-La Roche Ltd (Europe)
Table of Contents
1 Influenza Vaccination Market Overview
1.1 Product Overview and Scope of Influenza Vaccination
1.2 Classification of Influenza Vaccination by Type
1.2.1 Global Influenza Vaccination Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Global Influenza Vaccination Revenue Market Share by Type in 2019
1.2.3 Egg Based
1.2.4 Cell Culture
1.2.5 Recombinant
1.3 Global Influenza Vaccination Market by Application
1.3.1 Overview: Global Influenza Vaccination Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Hospitals
1.3.3 Research Organizations
1.4 Global Influenza Vaccination Market by Regions
1.4.1 Global Influenza Vaccination Market Size by Regions: 2015 VS 2019 VS 2025
1.4.2 Global Market Size of Influenza Vaccination (2015-2025)
1.4.3 North America (USA, Canada and Mexico) Influenza Vaccination Status and Prospect (2015-2025)
1.4.4 Europe (Germany, France, UK, Russia and Italy) Influenza Vaccination Status and Prospect (2015-2025)
1.4.5 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Influenza Vaccination Status and Prospect (2015-2025)
1.4.6 South America (Brazil, Argentina, Colombia) Influenza Vaccination Status and Prospect (2015-2025)
1.4.7 Middle East & Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Influenza Vaccination Status and Prospect (2015-2025)
2 Company Profiles
2.1 Abbott (U.S.)
2.1.1 Abbott (U.S.) Details
2.1.2 Abbott (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Abbott (U.S.) SWOT Analysis
2.1.4 Abbott (U.S.) Product and Services
2.1.5 Abbott (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific)
2.2.1 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Details
2.2.2 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) SWOT Analysis
2.2.4 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Product and Services
2.2.5 Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.3 Novartis AG (Europe)
2.3.1 Novartis AG (Europe) Details
2.3.2 Novartis AG (Europe) Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Novartis AG (Europe) SWOT Analysis
2.3.4 Novartis AG (Europe) Product and Services
2.3.5 Novartis AG (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.4 AstraZeneca (Europe)
2.4.1 AstraZeneca (Europe) Details
2.4.2 AstraZeneca (Europe) Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 AstraZeneca (Europe) SWOT Analysis
2.4.4 AstraZeneca (Europe) Product and Services
2.4.5 AstraZeneca (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.5 Hualan Biological Engineering Inc (Asia Pacific)
2.5.1 Hualan Biological Engineering Inc (Asia Pacific) Details
2.5.2 Hualan Biological Engineering Inc (Asia Pacific) Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Hualan Biological Engineering Inc (Asia Pacific) SWOT Analysis
2.5.4 Hualan Biological Engineering Inc (Asia Pacific) Product and Services
2.5.5 Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.6 BioCryst Pharmaceuticals, Inc. (U.S.)
2.6.1 BioCryst Pharmaceuticals, Inc. (U.S.) Details
2.6.2 BioCryst Pharmaceuticals, Inc. (U.S.) Major Business and Total Revenue (Financial Highlights) Analysis
2.6.3 BioCryst Pharmaceuticals, Inc. (U.S.) SWOT Analysis
2.6.4 BioCryst Pharmaceuticals, Inc. (U.S.) Product and Services
2.6.5 BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.7 Sanofi (Europe)
2.7.1 Sanofi (Europe) Details
2.7.2 Sanofi (Europe) Major Business and Total Revenue (Financial Highlights) Analysis
2.7.3 Sanofi (Europe) SWOT Analysis
2.7.4 Sanofi (Europe) Product and Services
2.7.5 Sanofi (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.8 GlaxoSmithKline plc. (Europe)
2.8.1 GlaxoSmithKline plc. (Europe) Details
2.8.2 GlaxoSmithKline plc. (Europe) Major Business and Total Revenue (Financial Highlights) Analysis
2.8.3 GlaxoSmithKline plc. (Europe) SWOT Analysis
2.8.4 GlaxoSmithKline plc. (Europe) Product and Services
2.8.5 GlaxoSmithKline plc. (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.9 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific)
2.9.1 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Details
2.9.2 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Major Business and Total Revenue (Financial Highlights) Analysis
2.9.3 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) SWOT Analysis
2.9.4 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Product and Services
2.9.5 DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
2.10 F. Hoffmann-La Roche Ltd (Europe)
2.10.1 F. Hoffmann-La Roche Ltd (Europe) Details
2.10.2 F. Hoffmann-La Roche Ltd (Europe) Major Business and Total Revenue (Financial Highlights) Analysis
2.10.3 F. Hoffmann-La Roche Ltd (Europe) SWOT Analysis
2.10.4 F. Hoffmann-La Roche Ltd (Europe) Product and Services
2.10.5 F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Revenue, Gross Margin and Market Share (2018-2019)
3 Market Competition, by Players
3.1 Global Influenza Vaccination Revenue and Share by Players (2015-2020)
3.2 Market Concentration Rate
3.2.1 Top 5 Influenza Vaccination Players Market Share
3.2.2 Top 10 Influenza Vaccination Players Market Share
3.3 Market Competition Trend
4 Market Size by Regions
4.1 Global Influenza Vaccination Revenue and Market Share by Regions
4.2 North America Influenza Vaccination Revenue and Growth Rate (2015-2020)
4.3 Europe Influenza Vaccination Revenue and Growth Rate (2015-2020)
4.4 Asia-Pacific Influenza Vaccination Revenue and Growth Rate (2015-2020)
4.5 South America Influenza Vaccination Revenue and Growth Rate (2015-2020)
4.6 Middle East & Africa Influenza Vaccination Revenue and Growth Rate (2015-2020)
5 North America Influenza Vaccination Revenue by Countries
5.1 North America Influenza Vaccination Revenue by Countries (2015-2020)
5.2 USA Influenza Vaccination Revenue and Growth Rate (2015-2020)
5.3 Canada Influenza Vaccination Revenue and Growth Rate (2015-2020)
5.4 Mexico Influenza Vaccination Revenue and Growth Rate (2015-2020)
6 Europe Influenza Vaccination Revenue by Countries
6.1 Europe Influenza Vaccination Revenue by Countries (2015-2020)
6.2 Germany Influenza Vaccination Revenue and Growth Rate (2015-2020)
6.3 UK Influenza Vaccination Revenue and Growth Rate (2015-2020)
6.4 France Influenza Vaccination Revenue and Growth Rate (2015-2020)
6.5 Russia Influenza Vaccination Revenue and Growth Rate (2015-2020)
6.6 Italy Influenza Vaccination Revenue and Growth Rate (2015-2020)
7 Asia-Pacific Influenza Vaccination Revenue by Countries
7.1 Asia-Pacific Influenza Vaccination Revenue by Countries (2015-2020)
7.2 China Influenza Vaccination Revenue and Growth Rate (2015-2020)
7.3 Japan Influenza Vaccination Revenue and Growth Rate (2015-2020)
7.4 Korea Influenza Vaccination Revenue and Growth Rate (2015-2020)
7.5 India Influenza Vaccination Revenue and Growth Rate (2015-2020)
7.6 Southeast Asia Influenza Vaccination Revenue and Growth Rate (2015-2020)
8 South America Influenza Vaccination Revenue by Countries
8.1 South America Influenza Vaccination Revenue by Countries (2015-2020)
8.2 Brazil Influenza Vaccination Revenue and Growth Rate (2015-2020)
8.3 Argentina Influenza Vaccination Revenue and Growth Rate (2015-2020)
9 Middle East & Africa Revenue Influenza Vaccination by Countries
9.1 Middle East & Africa Influenza Vaccination Revenue by Countries (2015-2020)
9.2 Saudi Arabia Influenza Vaccination Revenue and Growth Rate (2015-2020)
9.3 UAE Influenza Vaccination Revenue and Growth Rate (2015-2020)
9.4 Egypt Influenza Vaccination Revenue and Growth Rate (2015-2020)
9.5 South Africa Influenza Vaccination Revenue and Growth Rate (2015-2020)
10 Market Size Segment by Type
10.1 Global Influenza Vaccination Revenue and Market Share by Type (2015-2020)
10.2 Global Influenza Vaccination Market Forecast by Type (2019-2024)
10.3 Egg Based Revenue Growth Rate (2015-2025)
10.4 Cell Culture Revenue Growth Rate (2015-2025)
10.5 Recombinant Revenue Growth Rate (2015-2025)
11 Global Influenza Vaccination Market Segment by Application
11.1 Global Influenza Vaccination Revenue Market Share by Application (2015-2020)
11.2 Influenza Vaccination Market Forecast by Application (2019-2024)
11.3 Hospitals Revenue Growth (2015-2020)
11.4 Research Organizations Revenue Growth (2015-2020)
12 Global Influenza Vaccination Market Size Forecast (2021-2025)
12.1 Global Influenza Vaccination Market Size Forecast (2021-2025)
12.2 Global Influenza Vaccination Market Forecast by Regions (2021-2025)
12.3 North America Influenza Vaccination Revenue Market Forecast (2021-2025)
12.4 Europe Influenza Vaccination Revenue Market Forecast (2021-2025)
12.5 Asia-Pacific Influenza Vaccination Revenue Market Forecast (2021-2025)
12.6 South America Influenza Vaccination Revenue Market Forecast (2021-2025)
12.7 Middle East & Africa Influenza Vaccination Revenue Market Forecast (2021-2025)
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Data Source
14.3 Disclaimer
14.4 About US
Table 1. Global Influenza Vaccination Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Influenza Vaccination by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Influenza Vaccination Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Global Market Influenza Vaccination Revenue (Million USD) Comparison by Regions 2015-2025
Table 5. Abbott (U.S.) Corporate Information, Location and Competitors
Table 6. Abbott (U.S.) Influenza Vaccination Major Business
Table 7. Abbott (U.S.) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 8. Abbott (U.S.) SWOT Analysis
Table 9. Abbott (U.S.) Influenza Vaccination Product and Solutions
Table 10. Abbott (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 11. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Corporate Information, Location and Competitors
Table 12. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Major Business
Table 13. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Total Revenue (USD Million) (2018-2019)
Table 14. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) SWOT Analysis
Table 15. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Product and Solutions
Table 16. Mitsubishi Tanabe Pharma Corporation (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 17. Novartis AG (Europe) Corporate Information, Location and Competitors
Table 18. Novartis AG (Europe) Influenza Vaccination Major Business
Table 19. Novartis AG (Europe) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 20. Novartis AG (Europe) SWOT Analysis
Table 21. Novartis AG (Europe) Influenza Vaccination Product and Solutions
Table 22. Novartis AG (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 23. AstraZeneca (Europe) Corporate Information, Location and Competitors
Table 24. AstraZeneca (Europe) Influenza Vaccination Major Business
Table 25. AstraZeneca (Europe) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 26. AstraZeneca (Europe) SWOT Analysis
Table 27. AstraZeneca (Europe) Influenza Vaccination Product and Solutions
Table 28. AstraZeneca (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 29. Hualan Biological Engineering Inc (Asia Pacific) Corporate Information, Location and Competitors
Table 30. Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Major Business
Table 31. Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 32. Hualan Biological Engineering Inc (Asia Pacific) SWOT Analysis
Table 33. Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Product and Solutions
Table 34. Hualan Biological Engineering Inc (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 35. BioCryst Pharmaceuticals, Inc. (U.S.) Corporate Information, Location and Competitors
Table 36. BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Major Business
Table 37. BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 38. BioCryst Pharmaceuticals, Inc. (U.S.) SWOT Analysis
Table 39. BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Product and Solutions
Table 40. BioCryst Pharmaceuticals, Inc. (U.S.) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 41. Sanofi (Europe) Corporate Information, Location and Competitors
Table 42. Sanofi (Europe) Influenza Vaccination Major Business
Table 43. Sanofi (Europe) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 44. Sanofi (Europe) SWOT Analysis
Table 45. Sanofi (Europe) Influenza Vaccination Product and Solutions
Table 46. Sanofi (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 47. GlaxoSmithKline plc. (Europe) Corporate Information, Location and Competitors
Table 48. GlaxoSmithKline plc. (Europe) Influenza Vaccination Major Business
Table 49. GlaxoSmithKline plc. (Europe) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 50. GlaxoSmithKline plc. (Europe) SWOT Analysis
Table 51. GlaxoSmithKline plc. (Europe) Influenza Vaccination Product and Solutions
Table 52. GlaxoSmithKline plc. (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 53. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Corporate Information, Location and Competitors
Table 54. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Major Business
Table 55. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 56. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) SWOT Analysis
Table 57. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Product and Solutions
Table 58. DAIICHI SANKYO COMPANY, LIMITED. (Asia Pacific) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 59. F. Hoffmann-La Roche Ltd (Europe) Corporate Information, Location and Competitors
Table 60. F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Major Business
Table 61. F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Total Revenue (USD Million) (2017-2018)
Table 62. F. Hoffmann-La Roche Ltd (Europe) SWOT Analysis
Table 63. F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Product and Solutions
Table 64. F. Hoffmann-La Roche Ltd (Europe) Influenza Vaccination Revenue (USD Million), Gross Margin and Market Share (2018-2019)
Table 65. Global Influenza Vaccination Revenue (Million USD) by Players (2015-2020)
Table 66. Global Influenza Vaccination Revenue Share by Players (2015-2020)
Table 67. Global Influenza Vaccination Revenue (Million USD) by Regions (2015-2020)
Table 68. Global Influenza Vaccination Revenue Market Share by Regions (2015-2020)
Table 69. North America Influenza Vaccination Revenue by Countries (2015-2020)
Table 70. North America Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Table 71. Europe Influenza Vaccination Revenue (Million USD) by Countries (2015-2020)
Table 72. Asia-Pacific Influenza Vaccination Revenue (Million USD) by Countries (2015-2020)
Table 73. South America Influenza Vaccination Revenue by Countries (2015-2020)
Table 74. South America Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Table 75. Middle East and Africa Influenza Vaccination Revenue (Million USD) by Countries (2015-2020)
Table 76. Middle East and Africa Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Table 77. Global Influenza Vaccination Revenue (Million USD) by Type (2015-2020)
Table 78. Global Influenza Vaccination Revenue Share by Type (2015-2020)
Table 79. Global Influenza Vaccination Revenue Forecast by Type (2021-2025)
Table 80. Global Influenza Vaccination Revenue by Application (2015-2020)
Table 81. Global Influenza Vaccination Revenue Share by Application (2015-2020)
Table 82. Global Influenza Vaccination Revenue Forecast by Application (2021-2025)
Table 83. Global Influenza Vaccination Revenue (Million USD) Forecast by Regions (2021-2025)
List of Figures
Figure 1. Influenza Vaccination Picture
Figure 2. Global Influenza Vaccination Revenue Market Share by Type in 2019
Figure 3. Egg Based Picture
Figure 4. Cell Culture Picture
Figure 5. Recombinant Picture
Figure 6. Influenza Vaccination Revenue Market Share by Application in 2019
Figure 7. Hospitals Picture
Figure 8. Research Organizations Picture
Figure 9. Global Influenza Vaccination Revenue (USD Million) and Growth Rate (2015-2025)
Figure 10. North America Influenza Vaccination Revenue (Million USD) and Growth Rate (2015-2025)
Figure 11. Europe Influenza Vaccination Revenue (Million USD) and Growth Rate (2015-2025)
Figure 12. Asia-Pacific Influenza Vaccination Revenue (Million USD) and Growth Rate (2015-2025)
Figure 13. South America Influenza Vaccination Revenue (Million USD) and Growth Rate (2015-2025)
Figure 14. Middle East and Africa Influenza Vaccination Revenue (Million USD) and Growth Rate (2015-2025)
Figure 15. Global Influenza Vaccination Revenue (Million USD) and Growth Rate (2015-2025)
Figure 16. Global Influenza Vaccination Revenue Share by Players in 2019
Figure 17. Global Top 5 Players Influenza Vaccination Revenue Market Share in 2019
Figure 18. Global Top 10 Players Influenza Vaccination Revenue Market Share in 2019
Figure 19. Key Players Market Share Trend
Figure 20. Global Influenza Vaccination Revenue (Million USD) and Growth Rate (%) (2015-2020)
Figure 21. Global Influenza Vaccination Revenue Market Share by Regions (2015-2020)
Figure 22. Global Influenza Vaccination Revenue Market Share by Regions in 2018
Figure 23. North America Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 24. Europe Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 25. Asia-Pacific Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 26. South America Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 27. Middle East and Africa Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 28. North America Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Figure 29. North America Influenza Vaccination Revenue Market Share by Countries in 2019
Figure 30. USA Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 31. Canada Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 32. Mexico Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 33. Europe Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Figure 34. Europe Influenza Vaccination Revenue Market Share by Countries in 2019
Figure 35. Germany Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 36. UK Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 37. France Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 38. Russia Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 39. Italy Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Figure 41. Asia-Pacific Influenza Vaccination Revenue Market Share by Countries in 2019
Figure 42. China Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 43. Japan Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 44. Korea Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 45. India Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 46. Southeast Asia Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 47. South America Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Figure 48. South America Influenza Vaccination Revenue Market Share by Countries in 2019
Figure 49. Brazil Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 50. Argentina Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 51. Middle East and Africa Influenza Vaccination Revenue Market Share by Countries (2015-2020)
Figure 52. Middle East and Africa Influenza Vaccination Revenue Market Share by Countries in 2019
Figure 53. Saudi Arabia Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 54. UAE Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 55. Egypt Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 56. South Africa Influenza Vaccination Revenue and Growth Rate (2015-2020)
Figure 57. Global Influenza Vaccination Revenue Share by Type (2015-2020)
Figure 58. Global Influenza Vaccination Revenue Share by Type in 2019
Figure 59. Global Influenza Vaccination Market Share Forecast by Type (2021-2025)
Figure 60. Global Egg Based Revenue Growth Rate (2015-2020)
Figure 61. Global Cell Culture Revenue Growth Rate (2015-2020)
Figure 62. Global Recombinant Revenue Growth Rate (2015-2020)
Figure 63. Global Influenza Vaccination Revenue Share by Application (2015-2020)
Figure 64. Global Influenza Vaccination Revenue Share by Application in 2019
Figure 65. Global Influenza Vaccination Market Share Forecast by Application (2021-2025)
Figure 66. Global Hospitals Revenue Growth Rate (2015-2020)
Figure 67. Global Research Organizations Revenue Growth Rate (2015-2020)
Figure 68. Global Influenza Vaccination Revenue (Million USD) and Growth Rate Forecast (2021-2025)
Figure 69. Global Influenza Vaccination Revenue (Million USD) Forecast by Regions (2021-2025)
Figure 70. Global Influenza Vaccination Revenue Market Share Forecast by Regions (2021-2025)
Figure 71. North America Influenza Vaccination Revenue Market Forecast (2021-2025)
Figure 72. Europe Influenza Vaccination Revenue Market Forecast (2021-2025)
Figure 73. Asia-Pacific Influenza Vaccination Revenue Market Forecast (2021-2025)
Figure 74. South America Influenza Vaccination Revenue Market Forecast (2021-2025)
Figure 75. Middle East and Africa Influenza Vaccination Revenue Market Forecast (2021-2025)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
ワクチン・予防接種の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The global Vaccines & Vaccination market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Vaccines & Vaccination…- 一般インフルエンザ診断の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The General Influenza Diagnostics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optim…
- インフルエンザワクチンの世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Vaccine for Influenza market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- インフルエンザNA阻害剤の世界市場2020年：メーカー別、地域別、種類・用途別 Market Overview The Influenza NA Inhibitor market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization…
- 分子インフルエンザ検査の世界市場2020年：企業別、地域別、種類・用途別 Market Overview The Molecular Influenza Test market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimizati…